To Get Help Now
Click Here
Today's Date:

New Jersey Man Alleges Eli Lilly Testosterone Replacement Product Caused Him a Heart Attack

AddThis Social Bookmark Button

Drug maker Eli Lilly is facing a lawsuit filed by a New Jersey man in federal court in Newark over the company’s testosterone replacement drug Axiron.

According to the lawsuit, the patient stated that he began taking Axiron at age 54 in September 2012 and suffered a heart attack on October 3, 2012. Had the patient known that Axiron could increase users’ risk for heart attack, he would not have started taking it, the suit states.

Lilly advertises Axiron as a drug that treats “Low T,” a medical condition that the lawsuit calls a “non-existent and unrecognized medical condition,” the “symptoms” of which include decreased sexual desire, erectile dysfunction, fatigue and loss of energy, depressed mood, decreased strength and osteoporosis. Such symptoms, according to the suit, are actually normal indicators of an increase in age or weight. The suit states that “low testosterone is not a disease recognized by the medical community. Instead, it is a normal result of the aging process.” The U.S. Food and Drug Administration (FDA) approved Axiron for treatment of an endocrine condition known as hypogonadism, but a study found that only six percent of men have the disorder.

Lilly is accused of engaging in an aggressive “disease awareness campaign” designed to lead men to believe they are suffering from “Low T.” There is no drug approved by the FDA for the treatment of such a condition. According to the suit, Eli Lilly “manufactured, sold and promoted these drugs to treat a non-existent medical condition that the company calls ‘Low T,’ a name created for the constellation of symptoms experienced by men as a result of the normal aging process.” The patient alleges Lilly marketed and sold testosterone as a lifestyle drug aimed at making men feel younger and increasing their libido. The firm “successfully created a robust and previously nonexistent market for their drugs,” the suit alleges.

In the suit, the patient alleges failure to warn, defective design, defective manufacturing, negligence, breach of implied warranty, breach of express warranty, fraud and negligent misrepresentation. The patient is seeking compensatory and punitive damages, restitution, disgorgement of profits, injunctive relief and attorney fees.

In January, the FDA said it was investigating the risk for stroke, heart attack and death in men using testosterone replacement products. Testosterone replacement therapy cases industry-wide were consolidated in the Northern District of Illinois in June by the U.S. Judicial Panel on Multidistrict Litigation. Eli Lilly, AbbVie, Abbott Laboratories, Actavis and Auxilium Pharmaceuticals, Endo Pharmaceuticals and Pfizer are all facing lawsuits in the multidistrict litigation over testosterone. disclaimer: This article: New Jersey Man Alleges Eli Lilly Testosterone Replacement Product Caused Him a Heart Attack was posted on Thursday, October 2nd, 2014 at 2:44 pm at and is filed under Defective Drug Lawsuits, Misleading Information Lawsuits.

« »

Comments are closed.